1996
DOI: 10.1177/096120339600500202
|View full text |Cite
|
Sign up to set email alerts
|

SLE and osteoporosis: dependence and/or independence on glucocorticoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0
1

Year Published

1998
1998
2010
2010

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 34 publications
(16 citation statements)
references
References 16 publications
0
15
0
1
Order By: Relevance
“…To our knowledge, only a few studies have investigated the effect of oral corticosteroids on BMD in SLE, with discordant results [2,9,10,12,17]. Dykman, in a study on BMD in 33 patients with SLE, demonstrated that cumulative dosage of prednisone (over 30 mg) was the most important factor determining corticosteroid osteopenia [2].…”
Section: Discussionmentioning
confidence: 90%
See 2 more Smart Citations
“…To our knowledge, only a few studies have investigated the effect of oral corticosteroids on BMD in SLE, with discordant results [2,9,10,12,17]. Dykman, in a study on BMD in 33 patients with SLE, demonstrated that cumulative dosage of prednisone (over 30 mg) was the most important factor determining corticosteroid osteopenia [2].…”
Section: Discussionmentioning
confidence: 90%
“…Formiga et al found a significantly reduced BMD in 74 female SLE patients, but was not able to demonstrate any association between BMD and cumulative or baseline doses of corticosteroids [12]. Sels et al analyzed all the SLE patients (61 cases) reported in the literature, who had never received corticosteroid treatment; he found a modest loss of BMD at spine, hip and forearm, suggesting that osteopenia might be disease-related [17]. All these studies, however, were performed on adults and gave no prospective evaluation of mineralization during steroid therapy.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…Trapani et al also reported an association between the cumulative steroid dose and BMD in patients with childhood-onset SLE (13), whereas Castro et al did not observe such an association (12). The impact of corticosteroids have been a subject of controversy (19,42,43), but some of the differences between studies may be attributable to patient selection, study design, and different uses of corticosteroids (i.e., high-dose, low-dose, oral, intravenous). Interestingly, in our patients, corticosteroids were not identified as predictors of bone loss in the distal one-third of the radius and the total body.…”
Section: Osteopenia In Patients With Childhood-onset Slementioning
confidence: 99%
“…through decreased formation and increased resorption of bone (21,22), but the impact of corticosteroids on bone loss in the setting of SLE is unclear (6,9,10,19).…”
mentioning
confidence: 99%